닥플 플러스
제15차 International Congress on Lipid & Atherosclerosis (ICoLA 2026) 3일차
한국지질ㆍ동맥경화학회
연수평점 :6점
오프라인
주관
한국지질ㆍ동맥경화학회
교육일자
2026-09-12
수강료
140,000원
교육형태
오프라인
등록일시
2026-07-27
교육시간
24시간 45분
연수평점
6점
장소
서울특별시 콘래드 서울 호텔(그랜드볼룸1~3, 파크볼룸3, 스튜디오2~3)
교육종류
내과
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-09-12 | 07:50~08:10 | Statin Therapy Strategies for Newly Diagnosed Dyslipidemia Patients in Clinical Practice | Michal Vrablik(Charles University, Czech Republic) | - |
| 2026-09-12 | 08:10~08:20 | Q&A | - | - |
| 2026-09-12 | 08:30~08:50 | Break | - | - |
| 2026-09-12 | 08:50~09:05 | (Oral presentation) Residual Risk of Remnant Cholesterol in Patients Treated to LDL-C (Low-Density Lipoprotein Cholesterol) Goal: A Landmark Analysis of the RACING Trial | Sung Gyun AHN(Yonsei University, Republic of Korea) | - |
| 2026-09-12 | 09:05~09:20 | (Oral presentation) Lower Cardiovascular Event Risk With Bempedoic Acid Versus Ezetimibe in Statin-Intolerant ASCVD (Atherosclerotic Cardiovascular Disease): A 3,540-Patient TriNetX Analysis | Ahmed Elaraby(Al-Azhar University, Ireland) | - |
| 2026-09-12 | 09:20~09:35 | (Oral presentation) Age-dependent Association of Atherogenic Dyslipidemia with Incident Cardiovascular Disease: A Nationwide Korean Cohort Study | Ye Seul Yang(Seoul National University, Republic of Korea) | - |
| 2026-09-12 | 09:35~09:50 | (Oral presentation) Deep Learning Analysis of BMI (Body Mass Index), Metabolic Risk Factors, and Sex Hormones in U.S. Women: A NHANES (National Health and Nutrition Examination Survey) Study | Saheed Oladele Amusat(Beaumont Hospital, Malaysia) | - |
| 2026-09-12 | 09:50~10:05 | (Oral presentation) A Korean Multidimensional Social Determinants of Health Index Identifies Individuals at Elevated Risk of Severe Coronary Artery Calcification | Jooeun Jeon(Ewha Womans University, Republic of Korea) | - |
| 2026-09-12 | 10:05~10:20 | (Oral presentation) REAL-WORLD EFFICACY AND TOLERABILITY OF INCLISIRAN IN MALAYSIAN PATIENTS WITH ASCVD (Atherosclerotic Cardiovascular Disease): A Single-Centre Experience | Kim Fong Ng(KPJ Kluang Specialist Hospital) | - |
| 2026-09-12 | 10:20~10:40 | Coffee Break | - | - |
| 2026-09-12 | 10:40~11:20 | Beyond LDL-C (Low-Density Lipoprotein Cholesterol) Lowering: Strategies for Maximizing Residual ASCVD (Atherosclerotic Cardiovascular Disease) Risk Reduction | Nathan D. Wong(University of California, Irvine, USA) | - |
| 2026-09-12 | 11:20~12:00 | Perspective on residual risk, inflammation, and atherosclerosis: from epidemiology to precision prevention | Borge G. Nordestgaard(University of Copenhagen, Denmark) | - |
| 2026-09-12 | 12:00~13:00 | Lunch | - | - |
| 2026-09-12 | 13:00~13:15 | Residual cardiovascular risk in hypertension despite optimal BP(Blood Pressure) control | Hyue Mee Kim(Chung-Ang University, Republic of Korea) | - |
| 2026-09-12 | 13:15~13:30 | Lipid management in hypertensive patients | Jae Hoon Chung(Gachon University, Republic of Korea) | - |
| 2026-09-12 | 13:30~13:45 | Obesity, insulin resistance, and hypertension-related vascular injury | Mi Hye Seo(Soonchunhyang University, Republic of Korea) | - |
| 2026-09-12 | 13:45~14:00 | Discussion | - | - |
| 2026-09-12 | 14:00~14:10 | Break | - | - |
| 2026-09-12 | 14:10~14:30 | Cardiologist Perspective: Implementing Novel Cardiometabolic Therapies in CVD (Cardiovascular Disease) | Donna Shu-Han Lin(Shin Kong Wu Ho-Su Memorial Hospital, Taiwan) | - |
| 2026-09-12 | 14:30~14:50 | Nephrologist Perspective: Kidney Protection Strategies to Reduce CKD (Chronic Kidney Disease) Progression and CV (Cardiovascular) Risk | Jong Hyun Jhee(Yonsei University, Republic of Korea) | - |
| 2026-09-12 | 14:50~15:10 | Endocrinologist Perspective: Optimizing Combination Therapy in Complex CKM (Cardiovascular-Kidney-Metabolic) Patients | Jae-Seung Yun(The Catholic University of Korea, Republic of Korea) | - |
| 2026-09-12 | 15:10~15:40 | Discussion | - | - |
| 2026-09-12 | 15:40~15:50 | Break | - | - |
| 2026-09-12 | 15:50~16:10 | Host Genetics, Gut Microbiome, and Neural Pathways Linking Diet to Cardiometabolic Health | So Young Kwak(Kyungpook National University, Republic of Korea) | - |
| 2026-09-12 | 16:10~16:30 | Understanding Gene-Diet Interactions in Cardiometabolic Health | Sun Min Park(Hoseo University, Republic of Korea) | - |
| 2026-09-12 | 16:30~16:50 | Interaction Effects of Genetic Variants and Dietary Intake on the Development of Metabolic Syndrome: Evidence from a Korean Prospective Cohort | Da Yeon Shin(Ewha Womans University, Republic of Korea) | - |
| 2026-09-12 | 16:50~17:20 | Discussion | - | - |
| 2026-09-12 | 17:20~17:50 | Closing remark | - | - |
| 2026-09-12 | 08:05~08:20 | The role of low-dose fenofibrate in the management of dyslipidemia | Jae Seok Kim(Yonsei University, Republic of Korea) | - |
| 2026-09-12 | 08:20~08:30 | Q&A | - | - |
| 2026-09-12 | 08:30~08:50 | Break | - | - |
| 2026-09-12 | 08:50~09:10 | The Emerging Role of ApoB (Apolipoprotein B) and Triglyceride-Rich Lipoproteins | Sin Yung Woo(Konyang University, Republic of Korea) | - |
| 2026-09-12 | 09:10~09:30 | Inflammation and Immune Mechanisms: New Frontiers in Residual Cardiovascular Risk | Ping-Yen Liu(National Cheng Kung University, Taiwan) | - |
| 2026-09-12 | 09:30~09:50 | Cardiometabolic Residual Risk in Asia: Diabetes, Metabolic Dysfunction, and Vascular Aging | Min Kwan Kim(Yonsei University, Republic of Korea) | - |
| 2026-09-12 | 09:50~10:20 | Discussion | - | - |
| 2026-09-12 | 10:20~10:40 | Coffee Break | - | - |
| 2026-09-12 | 12:00~13:00 | Lunch | - | - |
| 2026-09-12 | 13:00~13:15 | Impact of Lipid-Lowering Therapy on Plaque Stabilization and Regression | Jong Young Lee(Hallym University, Republic of Korea) | - |
| 2026-09-12 | 13:15~13:30 | Coronary Microvascular Dysfunction After PCI (Percutaneous Coronary Intervention) | Hyun Sung Joh(Seoul National University, Republic of Korea) | - |
| 2026-09-12 | 13:30~13:45 | Discordance Between CAC (Coronary Artery Calcium) and Coronary Stenosis | Sang Hoon Shin(Ewha Womans University, Republic of Korea) | - |
| 2026-09-12 | 13:45~14:00 | Discussion | - | - |
| 2026-09-12 | 14:00~14:10 | Break | - | - |
| 2026-09-12 | 14:10~14:28 | AI (Artificial Intelligence)-CVD (Cardiovascular Disease): Opportunistic Testing of Coronary Calcium and Beyond | Nathan D. Wong(University of California, Irvine, USA) | - |
| 2026-09-12 | 14:28~14:46 | From Physics to Physiology: Computational Hemodynamics and Coronary Flow Modeling in Atherosclerosis | Joon Sang Lee(Yonsei University, Republic of Korea) | - |
| 2026-09-12 | 14:46~15:04 | Clinical Applications of AI (Artificial Intelligence) in Coronary Imaging | Si-Hyuck Kang(Seoul National University, Republic of Korea) | - |
| 2026-09-12 | 15:04~15:22 | AI (Artificial Intelligence)-Based Retinomics: Cardiovascular Risk Prediction Using Retinal Imaging | Sahil Thakur(Medical Affairs, Mediwhale Inc., Singapore) | - |
| 2026-09-12 | 15:22~15:40 | Discussion | - | - |
| 2026-09-12 | 15:40~15:50 | Break | - | - |
| 2026-09-12 | 15:50~16:10 | ESC (European Society of Cardiology)/EAS (European Atherosclerosis Society) Dyslipidemia Guidelines: Recent Updates and Evidence Base | Meral Kayikcioglu(Ege University, Izmir, Turkey) | - |
| 2026-09-12 | 16:10~16:30 | Korean Perspectives on Dyslipidemia Guidelines: Recent update and Challenges | Jae Hoon Chung(Gachon University, Republic of Korea) | - |
| 2026-09-12 | 16:30~16:50 | Translating Guidelines into Practice | Won Jin Kim(Cha University, Republic of Korea) | - |
| 2026-09-12 | 16:50~17:20 | Discussion | - | - |
| 2026-09-12 | 07:50~08:20 | A New Oral LDL-C (Low-Density Lipoprotein Cholesterol)-Lowering Agent with Proven CV (Cardiovascular) Benefit | Chang-Hee Jung(University of Ulsan, Republic of Korea) | - |
| 2026-09-12 | 08:20~08:30 | Q&A | - | - |
| 2026-09-12 | 08:30~08:50 | Break | - | - |
| 2026-09-12 | 08:50~09:10 | Oxidized Phospholipids on Lipoprotein(a): A Key Driver of Atherothrombosis? | Sotirios Tsimikas(University of California, San Diego, USA) | - |
| 2026-09-12 | 09:10~09:30 | Does Lipoprotein(a) Promote Thrombosis? Evidence from Genetics and Population Studies | Borge G. Nordestgaard(University of Copenhagen, Denmark) | - |
| 2026-09-12 | 09:30~09:50 | Epidemiology and Cardiovascular Events: What Have We Learned? | Sang-Rok Lee(Jeonbuk National University, Republic of Korea) | - |
| 2026-09-12 | 09:50~10:20 | Discussion | - | - |
| 2026-09-12 | 10:20~10:40 | Coffee Break | - | - |
| 2026-09-12 | 12:00~13:00 | Lunch | - | - |
| 2026-09-12 | 13:00~13:15 | Hypertriglyceridemia and remnant cholesterol in diabetes | Sung Hee Choi(Seoul National University, Republic of Korea) | - |
| 2026-09-12 | 13:15~13:30 | Arterial stiffness and vascular aging in diabetes | Hak Lyoung Kim(Seoul National University, Republic of Korea) | - |
| 2026-09-12 | 13:30~13:45 | Coronary artery calcium and subclinical atherosclerosis in diabetes | Jang Hoon Lee(Kyungpook National University, Republic of Korea) | - |
| 2026-09-12 | 13:45~14:00 | Discussion | - | - |
| 2026-09-12 | 14:00~14:10 | Break | - | - |
| 2026-09-12 | 14:10~14:30 | Lipid Management in Primary Prevention: Who, When, and How Aggressive? | Yeo Ree Yang(The Catholic University of Korea, Republic of Korea) | - |
| 2026-09-12 | 14:30~14:50 | Life’s Essential 8 and Beyond: Movement Behaviors and Cardiorespiratory Fitness | So Jung Lee(Kyunghee University, Republic of Korea) | - |
| 2026-09-12 | 14:50~15:10 | Advancing Cardiovascular Management Through Vaccination | Jae Hyoung Park(Korea University, Republic of Korea) | - |
| 2026-09-12 | 15:10~15:40 | Discussion | - | - |
| 2026-09-12 | 15:40~15:50 | Break | - | - |
| 2026-09-12 | 15:50~16:10 | Non-inflammatory function of dendritic cell in the regulation of obesity-associated heart failure | Kae Won Cho(Soonchunhyang University, Republic of Korea) | - |
| 2026-09-12 | 16:10~16:30 | Hepatic Lipotoxicity and Fibrotic Remodeling in Metabolic Liver Disease | KyeongJin Kim(Inha University, Republic of Korea) | - |
| 2026-09-12 | 16:30~16:50 | From Lipidomics to Systems Biology: Decoding Metabolic Networks | Guanghou Shui(Chinese Academy of Sciences, China) | - |
| 2026-09-12 | 16:50~17:20 | Discussion | - | - |
| 2026-09-12 | 07:50~08:05 | Integrated Lipid Management Across the CKM (Cardiovascular-Kidney-Metabolic) Spectrum: From Evidence to Practice | Jong-Chan Youn(The Catholic University of Korea, Republic of Korea) | - |
| 2026-09-12 | 08:05~08:20 | The Importance of Preventing Infectious Diseases and shingles in patient with Underlying Medical Conditions | Timothy C. Tan(Western Sydney University, Australia) | - |
| 2026-09-12 | 08:20~08:35 | Why Is LDL-C (Low-Density Lipoprotein Cholesterol) Control Still Insufficient? Finding the Breakthrough with Leqvio Cases in the Lipid-Lowering Therapy era | Jung-Joon Cha(Korea University, Republic of Korea) | - |
| 2026-09-12 | 08:35~08:40 | Q&A | - | - |
| 2026-09-12 | 08:40~08:50 | Break | - | - |
| 2026-09-12 | 08:50~09:10 | Dyslipidemia across Ethnicities in Malaysia: Who Is at Risk, and Who Is Being Left Behind? | Nor Ashikin Md Sari(University of Malaya, Malaysia) | - |
| 2026-09-12 | 09:10~09:30 | Genetic Architecture of Dyslipidemia and Cardiovascular Risk in East Asians: From Monogenic Variants to Polygenic Risk | Soo Heon Kwak(Seoul National University, Republic of Korea) | - |
| 2026-09-12 | 09:30~09:50 | Epidemiological trends of dyslipidemia in Korea and their implications for Asian populations | Ho Kyou Lee(Yonsei University, Republic of Korea) | - |
| 2026-09-12 | 09:50~10:20 | Discussion | - | - |
| 2026-09-12 | 10:20~10:40 | Coffee Break | - | - |
| 2026-09-12 | 12:00~13:00 | Lunch | - | - |
| 2026-09-12 | 14:00~14:10 | Break | - | - |
| 2026-09-12 | 14:10~14:30 | Diabetic Dyslipidemia: Targeting Residual Risk Beyond LDL-C Lowering | Kyung Soo Kim(Cha University, Republic of Korea) | - |
| 2026-09-12 | 14:30~14:50 | Subclinical Thyroid Dysfunction: When Should We Treat for Lipid Control? | Eu Jeong Ku(Seoul National University, Republic of Korea) | - |
| 2026-09-12 | 14:50~15:10 | Atherogenic Dyslipidemia in Women: PCOS, Menopause, and Cardiovascular Risk | Jeong Rang Park(Gyeongsang National University, Republic of Korea) | - |
| 2026-09-12 | 15:10~15:40 | Discussion | - | - |
| 2026-09-12 | 15:40~15:50 | Break | - | - |
| 2026-09-12 | 15:50~16:08 | Atherosclerosis and Atherosclerotic Cardiovascular Disease in Asia: The Knowledge Gap for the Determinants. | Dong Zhao(Capital Medical University Beijing Anzhen Hospital, China) | - |
| 2026-09-12 | 16:08~16:26 | Air pollution and cardiovascular disease | Jong Tae Lee(Korea University, Republic of Korea) | - |
| 2026-09-12 | 16:26~16:44 | Microplastics and Cardiovascular Health: Current Epidemiological Evidence and Challenges | Dong Wook Lee(Seoul National University, Republic of Korea) | - |
| 2026-09-12 | 16:44~17:02 | Climate change and cardiometabolic disease | Whan Hee Lee(Pusan National University, Republic of Korea) | - |
| 2026-09-12 | 17:02~17:20 | Discussion | - | - |
비고
-교수, 봉직의, 개원의 : 조기 등록 80,000원/100,000원 / 사전 등록 100,000원/120,000원 / 현장 등록 120,000원/140,000원-전임의, 전공의, 군의관/공보의, 연구원, 간호사, 영양사, 약사, 기업회원, 기타 : 조기 등록 50,000원 / 사전 등록 60,000원 / 현장 등록 70,000
문의처
담당자
ICoLA2026 준비사무국
연락처
02-6958-7061
이메일
lipid@planbear.co.kr